Cargando…

The Copenhagen test and treat hepatitis C in a mobile clinic study: a protocol for an intervention study to enhance the HCV cascade of care for people who inject drugs (T’N’T HepC)

INTRODUCTION: Injecting drug use is the primary driver of hepatitis C virus (HCV) infection in Europe. Despite the need for more engagement with care, people who inject drugs (PWID) are hard to reach with HCV testing and treatment. We initiated a study to evaluate the efficacy for testing and linkag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lazarus, Jeffrey Victor, Øvrehus, Anne, Demant, Jonas, Krohn-Dehli, Louise, Weis, Nina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Infectious Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654134/ https://www.ncbi.nlm.nih.gov/pubmed/33168560 http://dx.doi.org/10.1136/bmjopen-2020-039724

Ejemplares similares

Let's End HepC: Modelling Public Health Epidemiological Policies Applied to Hepatitis C in Spain
por: Lopes, Henrique, et al.
Publicado: (2022)

Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam–hepatitis C)
por: Rapoud, Delphine, et al.
Publicado: (2020)

Pharmacists' Opinions on the Implementation of HIV and HepC Point-of-Care-Testing in a U.S. Pharmacy Chain
por: So, Elizabeth, et al.
Publicado: (2019)

Randomised controlled trial conducted in injecting equipment provision sites to compare the effectiveness of different hepatitis C treatment regimens in people who inject drugs: A Direct obserVed therApy versus fortNightly CollEction study for HCV treatment—ADVANCE HCV protocol study
por: Inglis, Sarah K, et al.
Publicado: (2019)

Psychometric Validation of the Hepatitis C Symptom and Impact Questionnaire (HCV-SIQv4) in a Diverse Sample of Adults with Chronic Hepatitis C Virus Infection Treated with an Interferon-free Simeprevir-containing Regimen
por: Trigg, Andrew, et al.
Publicado: (2019)

Reaching mEthadone users Attending Community pHarmacies with HCV: an international cluster randomised controlled trial protocol (REACH HCV)
por: Byrne, Christopher, et al.
Publicado: (2020)

2895. Threats to Successful Elimination of Viral Hepatitis: Results from the Nationwide Treatment as Prevention for Hepatitis C (TraP HepC) Program in Iceland
por: Gottfredsson, Magnus, et al.
Publicado: (2019)

HCV seropositivity in inmates and in the general population: an averaging approach to establish priority prevention interventions
por: Roux, P, et al.
Publicado: (2014)

Changes in weight, body composition and metabolic parameters after switch to dolutegravir/lamivudine compared with continued treatment with dolutegravir/abacavir/lamivudine for virologically suppressed HIV infection (The AVERTAS trial): a randomised, open-label, superiority trial in Copenhagen, Denmark
por: Pedersen, Karen Brorup Heje, et al.
Publicado: (2023)

Screening a nation for hepatitis C virus elimination: a cross-sectional study on prevalence of hepatitis C and associated risk factors in the Rwandan general population
por: Umutesi, Justine, et al.
Publicado: (2019)

Plasmid-Mediated AmpC (pAmpC) Genotypes Among Uropathogenic Escherichia coli: A Hospital-Based Study From Western Uttar Pradesh
por: Rehana, Ismat, et al.
Publicado: (2023)

Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study
por: Zou, Xia, et al.
Publicado: (2015)

928. Major Decrease in Prevalence of Hepatitis C Viremia in Key Populations following the Second Year of Treatment as Prevention for Hepatitis C (TraP HepC) Program in Iceland
por: Gottfredsson, Magnus, et al.
Publicado: (2018)

Tuberculosis care cascade in Zambia - identifying the gaps in order to improve outcomes: a population-based analysis
por: Lungu, Patrick, et al.
Publicado: (2021)

A cross‐sectional, prospective ocular motor study in 72 patients with Niemann‐Pick disease type C
por: Bremova‐Ertl, Tatiana, et al.
Publicado: (2021)

Treatment as Prevention for Hepatitis C (TraP HepC). A Real-world Experience from the First 12 Months of a Nationwide Elimination Program in Iceland
por: Gottfredsson, Magnus, et al.
Publicado: (2017)

Exploring hepatitis C virus testing and treatment engagement over time in Melbourne, Australia: a study protocol for a longitudinal cohort study (EC-Experience Cohort study)
por: O’Keefe, Daniel, et al.
Publicado: (2022)

Study on the utility of a statewide counselling programme for improving mortality outcomes of patients with Staphylococcus aureus bacteraemia in Thuringia (SUPPORT): a study protocol of a cluster-randomised crossover trial
por: Weis, S, et al.
Publicado: (2017)

Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons
por: Martin, Natasha K, et al.
Publicado: (2013)

A Proof of Concept Study Demonstrating the Feasibility of a Text Message Prompt for Hepatitis C Testing in the 1945-1965 Birth Cohort
por: Fisk, Rebecca J, et al.
Publicado: (2019)

Prevalence of hepatitis C virus infection and its correlates in a rural area of southwestern China: a community-based cross-sectional study
por: Cheng, Wanting, et al.
Publicado: (2017)

Sensitivity of point-of-care testing C reactive protein and procalcitonin to diagnose urinary tract infections in Dutch nursing homes: PROGRESS study protocol
por: Kuil, Sacha D, et al.
Publicado: (2019)

Gender-Specific Frequency Distribution of Hepatitis C Virus Genotypes in Punjab province, Pakistan: A Clinically Significant Descriptive Cross-Sectional Study
por: Yousaf, Anam, et al.
Publicado: (2021)

For patients with rheumatic disease and hepatitis C infection: the end of interferon
por: Calabrese, Leonard H, et al.
Publicado: (2015)

Treatment as prevention for hepatitis C virus in Pakistan: mathematical modelling projections
por: Ayoub, Houssein H, et al.
Publicado: (2019)

C-reactive Protein Is a Diagnostic Tool for Postoperative Infection in Orthopaedics
por: Shetty, Saiganesh, et al.
Publicado: (2022)

Real-world Experiences in the Transplantation of Hepatitis C-NAAT–positive Organs
por: Steinbrink, Julie M., et al.
Publicado: (2023)

The syphilis care cascade: tracking the course of care after screening positive among men and transgender women who have sex with men in Lima, Peru
por: Tang, Eric C, et al.
Publicado: (2015)

Long-term benefit of hepatitis C therapy in a safety net hospital system: a cross-sectional study with median 5-year follow-up
por: Singal, Amit G, et al.
Publicado: (2013)

Prevalence Rate of Hepatitis C Among the Solid Waste Handler in Wardha City
por: Wanjari, Mayur B, et al.
Publicado: (2021)

The relationship between obesity, hemoglobin A1c and the severity of COVID-19 at an urban tertiary care center in New York City: a retrospective cohort study
por: Randhawa, Gurchetan, et al.
Publicado: (2021)

Long-term impact of the COVID-19 pandemic on self-management of chronic conditions among high-risk adults in the USA: protocol for the C3 observational cohort study
por: Lovett, Rebecca, et al.
Publicado: (2023)

On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017
por: Aas, Christer Frode, et al.
Publicado: (2020)

Seroprevalence of hepatitis C virus infection in Cameroon: a systematic review and meta-analysis
por: Bigna, Jean Joel, et al.
Publicado: (2017)

Characterizing the historical role of parenteral antischistosomal therapy in hepatitis C virus transmission in Egypt
por: Ayoub, Houssein H, et al.
Publicado: (2020)

Hepatitis C virus genotype analysis in patients with chronic hepatitis in North Eastern Bulgaria
por: Brady, Zarina, et al.
Publicado: (2019)

Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections
por: Stewart, Zoe A., et al.
Publicado: (2021)

C-reactive protein and the neutrophil-to-lymphocyte ratio on admission predicting bacteraemia with COVID-19
por: Ueda, Yoshitaka, et al.
Publicado: (2023)

Retrospective hepatitis C seroprevalence screening in the antenatal setting—should we be screening antenatal women?
por: Orkin, Chloe, et al.
Publicado: (2016)

Eight Weeks of Ledipasvir/Sofosbuvir in Kidney Transplant Recipients With Hepatitis C Genotype 1 Infection
por: Husson, Jennifer S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4d2bb1a7jgsqfc4hqs83qqskrt